Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Future placebo-controlled trials of disease modifying therapy in relapsing multiple sclerosis would be unethical: Commentary.
Early Relapsing Multiple Sclerosis.
Volumetric and Shape Analysis of the Thalamus and Striatum in Amnestic Mild Cognitive Impairment.
Neurodegeneration in MS and NMO: The Eye and the Blood.
Seronegative Neuromyelitis Optica: A Case Report of a Hispanic Male.
Navigating the Decision Space: Shared Medical Decision Making as Distributed Cognition.
Evaluation of Handwriting Movement Kinematics: From an Ecological to a Magnetic Resonance Environment.
Multiple sclerosis lesion in the medulla oblongata in a patient with takotsubo cardiomyopathy.
Multiple sclerosis and employment: Associations of psychological factors and work instability.
Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity.
Tolerance induction by bone marrow transplantation in a multiple sclerosis model.
Absence of Tau triggers age-dependent sciatic nerve morphofunctional deficits and motor impairment.
Multiple sclerosis relapses are associated with increased fatigue and reduced health-related quality of life - A post hoc analysis of the TEMSO and TOWER studies.
Carbon nanospheres mediated delivery of nuclear matrix protein SMAR1 to direct experimental autoimmune encephalomyelitis in mice.
Epigenetic control of oligodendrocyte development: adding new players to old keepers.
[Immune-mediated neuropathies].
Brain health: time matters in multiple sclerosis.
Active immunotherapy may delay disability in progressive MS.
Multi-Output Decision Trees for Lesion Segmentation in Multiple Sclerosis.
Patient preferences for treatment of multiple sclerosis with disease-modifying therapies: a discrete choice experiment.
GRAPE: a graphical pipeline environment for image analysis in adaptive magnetic resonance imaging.
Arzerra receives approval in Japan
Auditory information processing in rat genotypes with different dopaminergic properties.
Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues.
Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory disease.
Pages
« first
‹ previous
…
750
751
752
753
754
755
756
757
758
…
next ›
last »